Clostridium botulinum stained with Gentian violet. The bacterium produces a nerve toxin, which causes botulism, a rare, but serious paralytic disease. Image courtesy of the Centers for Disease Control and Prevention.

The Nanotechnology Characterization Laboratory (NCL) is collaborating with the Army to develop a candidate vaccine against botulism.

Under a collaboration agreement between the National Cancer Institute and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), NCL scientists will produce nanoparticle formulations for four compounds that block the activity of botulism-causing nerve toxins, which are among the most lethal of all poisons.

Pages